REPORT ID 3756

EMEA (Europe, Middle East and Africa) Aurora Kinase B Market Report 2017

Publish Date
14-Dec-17
Pages
109
Format
Electronic (PDF)

In this report, the EMEA Aurora Kinase B market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Aurora Kinase B for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Aurora Kinase B market competition by top manufacturers/players, with Aurora Kinase B sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
    AbbVie Inc
    Advenchen Laboratories LLC
    Aeterna Zentaris Inc
    Amgen Inc
    AstraZeneca Plc
    Chipscreen Biosciences Ltd
    Cielo Therapeutics Inc
    Sanofi
    Sareum Holdings Plc

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    AZD-2811
    CS-2164
    Danusertib
    Ilorasertib
    NMI-900
    Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Anaplastic Large Cell Lymphoma
    Kidney Cancer
    Lung Cancer
    Prostate Cancer
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Aurora Kinase B Market Report 2017
1 Aurora Kinase B Overview
    1.1 Product Overview and Scope of Aurora Kinase B
    1.2 Classification of Aurora Kinase B
        1.2.1 EMEA Aurora Kinase B Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Aurora Kinase B Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 AZD-2811
        1.2.4 CS-2164
        1.2.5 Danusertib
        1.2.6 Ilorasertib
        1.2.7 NMI-900
        1.2.8 Others
    1.3 EMEA Aurora Kinase B Market by Application/End Users
        1.3.1 EMEA Aurora Kinase B Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Anaplastic Large Cell Lymphoma
        1.3.3 Kidney Cancer
        1.3.4 Lung Cancer
        1.3.5 Prostate Cancer
        1.3.6 Others
    1.4 EMEA Aurora Kinase B Market by Region
        1.4.1 EMEA Aurora Kinase B Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Aurora Kinase B (2012-2022)
        1.5.1 EMEA Aurora Kinase B Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Aurora Kinase B Revenue and Growth Rate (2012-2022)

2 EMEA Aurora Kinase B Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Aurora Kinase B Market Competition by Players/Manufacturers
        2.1.1 EMEA Aurora Kinase B Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Aurora Kinase B Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Aurora Kinase B Sale Price by Players (2012-2017)
    2.2 EMEA Aurora Kinase B (Volume and Value) by Type/Product Category
        2.2.1 EMEA Aurora Kinase B Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Aurora Kinase B Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Aurora Kinase B Sale Price by Type (2012-2017)
    2.3 EMEA Aurora Kinase B (Volume) by Application
    2.4 EMEA Aurora Kinase B (Volume and Value) by Region
        2.4.1 EMEA Aurora Kinase B Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Aurora Kinase B Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Aurora Kinase B Sales Price by Region (2012-2017)

3 Europe Aurora Kinase B (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Aurora Kinase B Sales and Value (2012-2017)
        3.1.1 Europe Aurora Kinase B Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Aurora Kinase B Revenue and Growth Rate (2012-2017)
    3.2 Europe Aurora Kinase B Sales and Market Share by Type
    3.3 Europe Aurora Kinase B Sales and Market Share by Application
    3.4 Europe Aurora Kinase B Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Aurora Kinase B Sales Volume by Countries (2012-2017)
        3.4.2 Europe Aurora Kinase B Revenue by Countries (2012-2017)
        3.4.3 Germany Aurora Kinase B Sales and Growth Rate (2012-2017)
        3.4.4 France Aurora Kinase B Sales and Growth Rate (2012-2017)
        3.4.5 UK Aurora Kinase B Sales and Growth Rate (2012-2017)
        3.4.6 Russia Aurora Kinase B Sales and Growth Rate (2012-2017)
        3.4.7 Italy Aurora Kinase B Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Aurora Kinase B Sales and Growth Rate (2012-2017)

4 Middle East Aurora Kinase B (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Aurora Kinase B Sales and Value (2012-2017)
        4.1.1 Middle East Aurora Kinase B Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Aurora Kinase B Revenue and Growth Rate (2012-2017)
    4.2 Middle East Aurora Kinase B Sales and Market Share by Type
    4.3 Middle East Aurora Kinase B Sales and Market Share by Application
    4.4 Middle East Aurora Kinase B Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Aurora Kinase B Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Aurora Kinase B Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Aurora Kinase B Sales and Growth Rate (2012-2017)
        4.4.4 Israel Aurora Kinase B Sales and Growth Rate (2012-2017)
        4.4.5 UAE Aurora Kinase B Sales and Growth Rate (2012-2017)
        4.4.6 Iran Aurora Kinase B Sales and Growth Rate (2012-2017)

5 Africa Aurora Kinase B (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Aurora Kinase B Sales and Value (2012-2017)
        5.1.1 Africa Aurora Kinase B Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Aurora Kinase B Revenue and Growth Rate (2012-2017)
    5.2 Africa Aurora Kinase B Sales and Market Share by Type
    5.3 Africa Aurora Kinase B Sales and Market Share by Application
    5.4 Africa Aurora Kinase B Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Aurora Kinase B Sales Volume by Countries (2012-2017)
        5.4.2 Africa Aurora Kinase B Revenue by Countries (2012-2017)
        5.4.3 South Africa Aurora Kinase B Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Aurora Kinase B Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Aurora Kinase B Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Aurora Kinase B Sales and Growth Rate (2012-2017)

6 EMEA Aurora Kinase B Manufacturers/Players Profiles and Sales Data
    6.1 AbbVie Inc
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Aurora Kinase B Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 AbbVie Inc Aurora Kinase B Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Advenchen Laboratories LLC
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Aurora Kinase B Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Advenchen Laboratories LLC Aurora Kinase B Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Aeterna Zentaris Inc
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Aurora Kinase B Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Aeterna Zentaris Inc Aurora Kinase B Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Amgen Inc
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Aurora Kinase B Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Amgen Inc Aurora Kinase B Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 AstraZeneca Plc
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Aurora Kinase B Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 AstraZeneca Plc Aurora Kinase B Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Chipscreen Biosciences Ltd
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Aurora Kinase B Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Chipscreen Biosciences Ltd Aurora Kinase B Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Cielo Therapeutics Inc
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Aurora Kinase B Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Cielo Therapeutics Inc Aurora Kinase B Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Sanofi
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Aurora Kinase B Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Sanofi Aurora Kinase B Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Sareum Holdings Plc
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Aurora Kinase B Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Sareum Holdings Plc Aurora Kinase B Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview

7 Aurora Kinase B Manufacturing Cost Analysis
    7.1 Aurora Kinase B Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Aurora Kinase B

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Aurora Kinase B Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Aurora Kinase B Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Aurora Kinase B Market Forecast (2017-2022)
    11.1 EMEA Aurora Kinase B Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Aurora Kinase B Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Aurora Kinase B Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Aurora Kinase B Price and Trend Forecast (2017-2022)
    11.2 EMEA Aurora Kinase B Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Aurora Kinase B Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Aurora Kinase B Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Aurora Kinase B Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Aurora Kinase B Sales Forecast by Type (2017-2022)
    11.7 EMEA Aurora Kinase B Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer